Ms Rachel Sacks-Davis
Honorary (Fellow)
Melbourne School of Population and Global Health
54 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort
DOI: 10.1111/liv.162032024
Journal article
Phenotyping people with a history of injecting drug use within electronic medical records using an interactive machine learning approach
DOI: 10.1038/s41746-024-01318-y2024
Journal article
Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C: A systematic review
DOI: 10.1016/j.drugpo.2024.1045622024
Journal article
Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study
DOI: 10.3390/cancers161527452024
Journal article
Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020
DOI: 10.1093/ofid/ofae0992024
Journal article
Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020
DOI: 10.1111/liv.158412024
Journal article
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
DOI: 10.1016/S2352-3018(23)00267-9
RECENT SCHOLARLY WORKS
2024
Journal article
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019
DOI: 10.1016/j.drugpo.2023.1043112024
Journal article
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
DOI: 10.1093/ije/dyad1542024
Journal article
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy
DOI: 10.3389/fimmu.2024.1352440